ALFA tracks holdings selected from quarterly hedge fund disclosures. The SEC Form 13F, or Information Required of Institutional Investment Managers Form, is a quarterly filing required of institutional managers with over $100 million in qualifying assets. The filing contains information on the manager’s list of recent investing holdings, which provide the public a glimpse of how the heavy weights are moving around the changing markets. [Hedge Fund ETFs Could be Vulnerable in Volatile Markets]
The $526.8 million PowerShares Dynamic Biotechnology & Genome Portfolio (NYSEArca: PBE) also has legitimate Pharmacyclics credibility. That ETF, which is up nearly 10% this year, had a 5% Pharmacyclics as of March 3, making the stock the ETF’s sixth-largest holding.
PBE’s underlying index evaluates companies for inclusion based on “price momentum, earnings momentum, quality, management action, and value,” according to PowerShares.
PowerShares Dynamic Biotechnology & Genome Portfolio
